Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 (eCardioCovid19)
Angina Pectoris, Acute Coronary Syndrome, Coronary Syndrome
About this trial
This is an interventional health services research trial for Angina Pectoris focused on measuring e-Health, Tele-Medicine, Remote medical surveillance, psychological counseling
Eligibility Criteria
Inclusion Criteria:
all known cardiovascular patients from local Cardiology Clinics, with:
- all spectrum of coronary syndromes (chronic to acute) +/- known coronary angioplasties;
- treated arterial hypertension;
- known congestive heart failure
- AND isolated / quarantined recommendations (due to COVID 19 pandemic).
Exclusion Criteria:
- refusal / denial to create an electronic account on this dedicated platform;
- refusal to accept wearable devices (ecg watches, oximetry).
Sites / Locations
- Medical Sciences AcademyRecruiting
- University of Medicine and Pharmacy Gr T PopaRecruiting
Arms of the Study
Arm 1
Experimental
All patients with known cardiovascular disease
All these patients will be provided an electronic account on a dedicated platform were they can be supervised and can call for advice / help. This kind of tele-medical project aims to keep these patients in a so-called proximity, monitoring their vital parameters, checking their medication and providing dedicated advices according to their complaints. Moreover, all these patients will receive digital watches with ecg-recording capabilities, thus a dedicated physician could correlate their symptoms with few clear paraclinical variables. All of these patients' complaints will be stratified according to elaborated protocols based on the European Cardiovascular Guidelines. Moreover, a psychologist and a chaplain will deal with their (new) problems due to social isolation.